mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.002 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |